Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens.

Shearer JD, Saylor ML, Butler CM, Treston AM, Heine HS, Chirakul S, Schweizer HP, Louie A, Drusano GL, Zumbrun SD, Warfield KL.

Antimicrob Agents Chemother. 2019 Sep 23. pii: AAC.00834-19. doi: 10.1128/AAC.00834-19. [Epub ahead of print]

2.

Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.

Chirakul S, Somprasong N, Norris MH, Wuthiekanun V, Chantratita N, Tuanyok A, Schweizer HP.

Int J Antimicrob Agents. 2019 May;53(5):582-588. doi: 10.1016/j.ijantimicag.2019.01.003. Epub 2019 Jan 9.

PMID:
30639528
3.

Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.

Rhodes KA, Somprasong N, Podnecky NL, Mima T, Chirakul S, Schweizer HP.

Microbiology. 2018 Sep;164(9):1156-1167. doi: 10.1099/mic.0.000691. Epub 2018 Jul 19.

4.

Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.

Chirakul S, Norris MH, Pagdepanichkit S, Somprasong N, Randall LB, Shirley JF, Borlee BR, Lomovskaya O, Tuanyok A, Schweizer HP.

Sci Rep. 2018 Jul 13;8(1):10652. doi: 10.1038/s41598-018-28843-7.

5.

Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.

Norris MH, Khan MSR, Chirakul S, Schweizer HP, Tuanyok A.

Vaccines (Basel). 2018 Jan 10;6(1). pii: E5. doi: 10.3390/vaccines6010005.

6.

Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm.

Podnecky NL, Rhodes KA, Mima T, Drew HR, Chirakul S, Wuthiekanun V, Schupp JM, Sarovich DS, Currie BJ, Keim P, Schweizer HP.

MBio. 2017 Sep 5;8(5). pii: e01357-17. doi: 10.1128/mBio.01357-17.

7.

Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.

Bugrysheva JV, Sue D, Gee JE, Elrod MG, Hoffmaster AR, Randall LB, Chirakul S, Tuanyok A, Schweizer HP, Weigel LM.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00010-17. doi: 10.1128/AAC.00010-17. Print 2017 Jun.

8.

Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model.

Chirakul S, Bartpho T, Wongsurawat T, Taweechaisupapong S, Karoonutaisiri N, Talaat AM, Wongratanacheewin S, Ernst RK, Sermswan RW.

PLoS One. 2014 Aug 11;9(8):e104313. doi: 10.1371/journal.pone.0104313. eCollection 2014.

9.

Effective screening for double heterozygosity of Hb E/alpha0-thalassemia.

Sanchaisuriya K, Chirakul S, Srivorakun H, Fucharoen G, Fucharoen S, Changtrakul Y, Sanchaisuriya P.

Ann Hematol. 2008 Nov;87(11):911-4. doi: 10.1007/s00277-008-0520-x. Epub 2008 Jun 25.

PMID:
18575861

Supplemental Content

Loading ...
Support Center